Cardiac hypertrophy is a common condition often predisposing to heart failure and sudden death. Despite recent progress in the identification of cellular signaling pathways involved in cardiac hypertrophic growth, little is known about the downstream molecular events that lead to contractile dysfunction in the hypertrophied heart. The expression of enzymes involved in mitochondrial fatty acid oxidation (FAO), the chief cardiac energy source, is coordinately downregulated in acquired forms of pathologic cardiac hypertrophy. We have recently demonstrated that this metabolic regulatory switch is due to deactivation of a transcriptional regulatory complex comprised of the nuclear receptor, PPARalpha, and its cardiac-enriched, coactivator PGC- 1. This renewal proposal is designed to test the hypothesis that the activity of PPARalpha/PGC-l plays a critical role in determining whether the hypertrophied heart becomes dysfunctional (pathologic remodeling) or maintains normal function as with physiologic forms of hypertrophy. We propose that the activity of PPARalpha is influenced by a balance of upstream signaling pathways linked to growth stimuli. The experiments planned for Specific Aim 1 are designed to characterize the upstream signaling events controlling the activity of the PPARalpha/PGC-1 complex and its target genes involved in mitochondrial metabolism during hypertrophic growth. The goal of Specific Aim 2 will be to evaluate the regulation of this energy metabolic pathway during physiologic hypertrophic growth due to exercise training. The objective of Specific Aim 3 is to systematically evaluate the effects of PPARalpha and PGC-1 in pathologic forms of cardiac hypertrophy using gain-of-function and loss-of-function genetic strategies in mice. The cardiac phenotype of these mice will be evaluated using molecular biologic, physiologic, and metabolic endpoints. Experiments proposed in Specific Aim 4 will evaluate the cardiac metabolic and functional response of mice lacking PPARalpha or PGC- 1 to exercise training. The longterm objective of this project is to identify molecular targets for novel therapeutic strategies aimed at preventing the pathologic metabolic remodeling of the hypertrophied heart.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL058493-08
Application #
6867303
Study Section
Cardiovascular and Pulmonary Research A Study Section (CVA)
Program Officer
Buxton, Denis B
Project Start
1998-04-01
Project End
2006-06-30
Budget Start
2005-04-01
Budget End
2006-06-30
Support Year
8
Fiscal Year
2005
Total Cost
$306,000
Indirect Cost
Name
Washington University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Gan, Zhenji; Fu, Tingting; Kelly, Daniel P et al. (2018) Skeletal muscle mitochondrial remodeling in exercise and diseases. Cell Res 28:969-980
Vega, Rick B; Kelly, Daniel P (2017) Cardiac nuclear receptors: architects of mitochondrial structure and function. J Clin Invest 127:1155-1164
Vega, Rick B; Konhilas, John P; Kelly, Daniel P et al. (2017) Molecular Mechanisms Underlying Cardiac Adaptation to Exercise. Cell Metab 25:1012-1026
Horton, Julie L; Martin, Ola J; Lai, Ling et al. (2016) Mitochondrial protein hyperacetylation in the failing heart. JCI Insight 2:
Liang, Xijun; Liu, Lin; Fu, Tingting et al. (2016) Exercise Inducible Lactate Dehydrogenase B Regulates Mitochondrial Function in Skeletal Muscle. J Biol Chem 291:25306-25318
Liu, Jing; Liang, Xijun; Zhou, Danxia et al. (2016) Coupling of mitochondrial function and skeletal muscle fiber type by a miR-499/Fnip1/AMPK circuit. EMBO Mol Med 8:1212-1228
Aubert, Gregory; Martin, Ola J; Horton, Julie L et al. (2016) The Failing Heart Relies on Ketone Bodies as a Fuel. Circulation 133:698-705
Weinheimer, Carla J; Lai, Ling; Kelly, Daniel P et al. (2015) Novel mouse model of left ventricular pressure overload and infarction causing predictable ventricular remodelling and progression to heart failure. Clin Exp Pharmacol Physiol 42:33-40
Ping, Peipei; Gustafsson, Åsa B; Bers, Don M et al. (2015) Harnessing the Power of Integrated Mitochondrial Biology and Physiology: A Special Report on the NHLBI Mitochondria in Heart Diseases Initiative. Circ Res 117:234-8
Gong, Guohua; Song, Moshi; Csordas, Gyorgy et al. (2015) Parkin-mediated mitophagy directs perinatal cardiac metabolic maturation in mice. Science 350:aad2459

Showing the most recent 10 out of 63 publications